RLAYRelay Therapeutics, Inc.
$17.88+284% 1Y
$17.88
$4.3852 weeks$20.77
Is the price fair?
What RLAY's price assumes
Relay Therapeutics, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 253× revenue.
253
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 6.85
Price / book · today's price, fiscal year to Dec 31, 2025
- EV / sales
- 248
EV / sales
Details›
- Price / booktoday's price, fiscal year to Dec 31, 2025
- 6.85
- EV / EBIToperating margin −2999%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, fiscal year to Dec 31, 2025
- 248
- Market capitalisation
- $3.89B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks